Close

Jefferies Resumes BioScrip (BIOS) at Buy

Go back to Jefferies Resumes BioScrip (BIOS) at Buy

BioScrip (BIOS) Misses Q3 EPS by 7c

November 7, 2016 5:19 PM EST

BioScrip (NASDAQ: BIOS) reported Q3 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $224.5 million versus the consensus estimate of $223.26 million.

The Company reconfirms its plan to achieve between $14 million to $17 million in Home Solutions cost synergies... More